Monitoring

Your Organisational Guidance

ebpracticenet urges you to prioritise the following organisational guidance:

Behandeling acuut cardiogeen longoedeem in een urgente situatie (in afwachting van hospitalisatie)Published by: Werkgroep Ontwikkeling Richtlijnen Eerste Lijn (Worel)Last published: 2022La prise en charge de l’oedème pulmonaire aigu cardiogénique en situation d'urgence (en attente d'une hospitalisation)Published by: Groupe de Travail Développement de recommmandations de première ligneLast published: 2022

During the acute phase all patients require cardiac monitoring. Other types of monitoring might also be indicated, depending on drugs used: for example, renal function, electrolytes, heart rate, blood pressure, and overall clinical status should be closely monitored during treatment with beta-blockers, aldosterone antagonists, or angiotensin-converting enzyme inhibitors; renal function, weight, and urine output should be closely monitored during diuretic therapy.[23]

After discharge from hospital, a follow-up clinical assessment should be undertaken by a member of the specialist heart failure team within 2 weeks.[23] Follow-up arrangements should be clearly documented.[4]

Once the acute phase is over and patients are stable and considered to have stable heart failure, they should be encouraged to do regular aerobic exercise, and it is recommended that they be enrolled in a multidisciplinary care management programme.[1]

Use of this content is subject to our disclaimer